Chapter 4
Microbiology, Immunology and Infection Prevention
Post Graduate Program in Health Care Management
Basic Health Sciences & Epidemiology
•
Post Graduate
Microbiology, Immunology and Infection Prevention
Introduction and Context
Healthcare organizations are environments in which microorganisms, susceptible hosts, invasive procedures, antimicrobial medicines, and complex patterns of contact coexist. Microbiology explains the organisms that cause infection; immunology explains how the host detects and controls them; infection prevention translates this knowledge into operational systems that protect patients, staff, and communities.
For health-care managers, infection prevention is not only a clinical responsibility. It is also a governance, quality, occupational-safety, supply-chain, information-management, and risk-management function. An outbreak may increase mortality, length of stay, expenditure, litigation exposure, and reputational damage. Effective programs therefore combine scientific knowledge with surveillance, reliable processes, trained personnel, environmental controls, and accountable leadership.
Learning Objectives
By the end of this chapter, the reader should be able to:
Distinguish major groups of human pathogens and relate their biological properties to disease and control.
Explain chains of infection and the principal routes of transmission.
Describe innate and adaptive host defenses, vaccination, and clinically relevant immunity.
Compare cleaning, disinfection, antisepsis, and sterilization.
Apply standard precautions, transmission-based precautions, isolation, and occupational-safety principles.
Interpret basic infection-control surveillance measures and recognize their limitations.
Explain antimicrobial resistance and design organizational antimicrobial-stewardship interventions.
Analyze infection-prevention problems as system and management problems rather than as failures of individuals alone.
1. The Microbial World and Human Disease
Microorganisms include bacteria, viruses, fungi, protozoa, and microscopic helminths. Not all microorganisms are harmful. The normal microbiota of skin, gut, respiratory tract, and other sites can provide colonization resistance, produce useful metabolites, and support immune development. Disease occurs when a pathogen enters a suitable site, evades defenses, multiplies, and damages tissues directly or through toxins and immune responses.
1.1 Major pathogen groups
Group
Core characteristics
Examples
Important control implications
Bacteria
Single-celled prokaryotes; may produce toxins, capsules, spores, or biofilms
Misfolded infectious proteins without conventional nucleic acid
Creutzfeldt–Jakob disease agents
Special instrument-processing and tissue-handling requirements
Bacterial spores are highly resistant structures produced by some bacteria, such as Bacillus and Clostridium. They should not be confused with fungal spores. Biofilms are structured microbial communities attached to surfaces and embedded in extracellular material. They can form on catheters, prostheses, and plumbing systems and may be less susceptible to antimicrobial treatment than free-floating organisms.
1.2 Colonization, infection, and disease
Colonization means the presence and multiplication of microorganisms without tissue damage or symptoms. Infection implies invasion or multiplication associated with a host response; disease refers to clinically significant impairment or symptoms. A patient may be colonized with methicillin-resistant S. aureus without having an active infection. This distinction matters because unnecessary treatment of colonization promotes adverse effects and resistance.
Healthcare-associated infections (HAIs) are infections acquired during or as a result of healthcare delivery. Examples include catheter-associated urinary tract infection, central-line-associated bloodstream infection, surgical-site infection, and ventilator-associated pneumonia. Definitions must be standardized if data are to be compared across wards, facilities, or time periods.
2. The Chain of Infection and Transmission
The chain of infection is a practical model with six links: infectious agent, reservoir, portal of exit, mode of transmission, portal of entry, and susceptible host. Prevention can interrupt any link. For example, vaccination reduces host susceptibility; respiratory hygiene reduces exit and transmission; sterilization removes organisms from instruments; and safe injection practice prevents entry through contaminated equipment.
Six links in the chain of infection and points of control
Figure: Six links in the chain of infection and points of control
Figure: The chain of infection. Infection prevention can act at every link rather than relying on a single barrier.
2.1 Modes of transmission
Contact transmission may be direct, such as skin-to-skin spread, or indirect through hands, instruments, clothing, and surfaces. Hand hygiene and equipment decontamination are central controls.
Droplet transmission involves respiratory particles that generally travel a limited distance and contact mucous membranes. Source control, appropriate masks, ventilation, and spatial separation are important.
Airborne transmission involves very small particles that may remain suspended and travel through air currents. Examples include tuberculosis, measles, and varicella. Controls may require respiratory protection, specialized ventilation, and limiting patient movement.
Common-vehicle transmission occurs through contaminated food, water, medication, blood, or equipment. Safe injection practice and food, water, and pharmaceutical controls are essential.
Vector-borne transmission involves mosquitoes, ticks, flies, or other vectors. It is particularly relevant to public-health and travel medicine.
A single pathogen can use several routes. Control measures must therefore be based on an evidence-based risk assessment, not on a label applied mechanically.
3. Host Defense and Immunity
3.1 Innate immunity
Innate immunity is rapid and broadly acting. Physical barriers include intact skin, mucous membranes, cilia, tears, saliva, and the normal flow of urine. Chemical defenses include gastric acidity, antimicrobial peptides, and enzymes such as lysozyme. The microbiota competes with pathogens for nutrients and attachment sites.
When barriers are breached, innate immune cells recognize conserved microbial patterns through pattern-recognition receptors. Neutrophils and macrophages ingest organisms; natural killer cells destroy some infected or abnormal cells; complement proteins promote inflammation, opsonization, and lysis. Inflammation increases blood flow and recruits immune cells, but excessive inflammation can damage organs.
3.2 Adaptive immunity
Adaptive immunity is antigen-specific and develops immunological memory. B lymphocytes produce antibodies, while T lymphocytes coordinate responses or kill infected cells. CD4-positive T cells help regulate immune responses; CD8-positive cytotoxic T cells destroy infected cells. Antibodies can neutralize toxins and viruses, promote phagocytosis, and activate complement.
Primary responses develop after first exposure and are usually slower. Secondary responses are faster and stronger because memory cells persist. Immunodeficiency may result from disease, malnutrition, medicines, congenital conditions, or aging. Immunocompromised patients may show atypical symptoms and require modified prevention strategies.
3.3 Active and passive immunity
Active immunity develops when the person’s immune system responds to infection or vaccination. It is generally longer lasting but takes time to develop. Passive immunity results from transferred antibodies, such as maternal antibodies or administered immunoglobulin. It acts rapidly but is temporary and may interfere with some vaccine responses.
3.4 Vaccination
Vaccines expose the immune system to an antigen or genetic instruction without causing the target disease in its usual form. Vaccine platforms include live attenuated, inactivated, subunit, conjugate, toxoid, viral-vector, and nucleic-acid vaccines. Protection depends on the vaccine, schedule, age, immune status, circulating variant, and time since vaccination.
At the population level, vaccination can reduce transmission by lowering the number of susceptible hosts. However, no vaccine is perfectly effective, and high coverage does not eliminate the need for hand hygiene, ventilation, diagnosis, and isolation. Managers should support accurate records, cold-chain integrity, informed consent, adverse-event reporting, equitable access, and staff vaccination programs.
4. Cleaning, Disinfection, Antisepsis, and Sterilization
These terms describe different levels of microbial control:
Cleaning removes soil and organic material, usually with detergent and water. It may reduce microorganisms but does not reliably destroy them.
Disinfection destroys many or all pathogenic microorganisms on inanimate objects, but may not reliably destroy bacterial spores.
Antisepsis applies antimicrobial chemicals to living tissue, such as skin.
Sterilization destroys or removes all forms of microbial life, including bacterial spores, when a validated process is correctly used.
Cleaning is often a prerequisite for disinfection or sterilization because blood, protein, and other organic matter can shield microorganisms and inactivate chemicals. The Spaulding classification supports selection of processing intensity:
Item category
Contact
Minimum processing expectation
Critical
Sterile tissue or vascular system
Sterilization
Semicritical
Mucous membranes or non-intact skin
High-level disinfection at minimum, or sterilization where feasible
Noncritical
Intact skin
Cleaning and low-level disinfection when indicated
Common sterilization methods include saturated steam under pressure, dry heat, ethylene oxide, hydrogen-peroxide-based systems, and other validated low-temperature technologies. The correct cycle depends on device material, load configuration, packaging, temperature, pressure, exposure time, and manufacturer instructions. Sterilization must be monitored mechanically, chemically, and, at defined intervals or after failures, biologically using resistant indicators.
Disinfectant effectiveness depends on concentration, contact time, temperature, pH, surface condition, and the organism. A surface that appears wet for only a few seconds may not have received the labeled contact time. Managers should ensure that products are approved, correctly diluted, labeled, stored, and used with occupational-safety controls. Mixing chemicals can create toxic gases or reduce effectiveness.
5. Standard and Transmission-Based Precautions
Standard precautions apply to every patient, regardless of diagnosis. They include risk-assessed hand hygiene; appropriate use of gloves, gowns, masks, and eye protection; respiratory hygiene; safe injection and sharps practices; environmental cleaning; appropriate reprocessing of equipment; and safe handling of linen and waste.
Hand hygiene is required before touching a patient, before a clean or aseptic procedure, after body-fluid exposure risk, after touching a patient, and after touching the patient’s surroundings. Gloves do not replace hand hygiene. Alcohol-based hand rub is usually preferred when hands are not visibly soiled; soap and water are required in situations where physical removal is necessary, including some spore-forming or gastroenteritis-associated contexts according to local guidance.
Transmission-based precautions supplement standard precautions:
Contact precautions: dedicated equipment, gown and gloves according to risk, and appropriate room placement.
Droplet precautions: medical mask, source control, and spatial or room separation.
Airborne precautions: fit-tested respirator or equivalent, appropriate ventilation, and controlled patient movement.
Isolation policies should be clinically justified, communicated respectfully, and reviewed regularly. They must protect patients without creating unnecessary stigma, delayed care, or inequitable access to services. Visitors and staff require clear instructions rather than assumptions about prior knowledge.
6. Infection-Control Surveillance and Quality Improvement
Surveillance is the systematic collection, analysis, interpretation, and dissemination of health data for action. It differs from passive counting because useful surveillance defines cases, identifies populations at risk, detects trends, and links results to interventions.
A basic incidence proportion is:
Incidence proportion = New cases during a specified period ÷ Population at risk at the start of the period
The result is dimensionless and may be expressed as a proportion or multiplied by 100 for a percentage. The denominator must exclude people who already have the condition and should represent the population genuinely at risk.
For device-associated infections, a rate commonly uses device-days:
Device-associated infection rate = Number of infections ÷ Number of device-days × 1,000
The multiplier, such as 1,000, is a reporting convention. Device-days are the total number of days on which patients were exposed to the device. Rates should not be compared without considering case definitions, surveillance intensity, patient mix, device utilization, diagnostic practices, and data quality.
A surveillance cycle includes: define the objective; establish standardized case definitions; identify numerator and denominator; collect and validate data; analyze trends and stratify by unit; provide timely feedback; implement interventions; and evaluate whether outcomes improve. Statistical signals should prompt investigation, not automatic blame. Small units may show large fluctuations because a few cases substantially change the rate.
Useful governance indicators include hand-hygiene performance, bundle adherence, time to isolation, environmental-cleaning quality, vaccination coverage, culture turnaround time, antimicrobial use, and resistance patterns. Process indicators should complement outcome indicators: a low infection rate may reflect under-detection, whereas high compliance with a prevention bundle indicates whether the system is functioning.
7. Antimicrobial Resistance and Stewardship
Antimicrobial resistance (AMR) occurs when microorganisms survive exposure to medicines that would previously have inhibited or killed them. Resistance can arise through mutation and spread through horizontal gene transfer, including plasmids. Selection pressure from unnecessary, overly broad, incorrectly dosed, or unnecessarily prolonged therapy favors resistant organisms.
Resistance is accelerated by poor infection prevention, inadequate diagnostics, substandard medicines, agricultural use, environmental contamination, and international movement. It is a One Health issue involving human, animal, and environmental systems.
Antimicrobial stewardship is a coordinated set of actions that promotes appropriate antimicrobial selection, dose, route, and duration. Core interventions include:
Obtain appropriate cultures before treatment when this will not dangerously delay therapy.
Use local antibiograms and clinical guidelines.
Start empiric therapy according to severity and likely pathogens.
Reassess at a defined time, often 48–72 hours, when clinical and microbiological information is available.
De-escalate, stop, change to oral therapy, or adjust dose when justified.
Monitor renal function, allergies, interactions, toxicity, and therapeutic response.
Audit prescribing and provide feedback.
Restrict selected agents through authorization or prospective review.
Stewardship must not become undertreatment. The ethical balance is to provide effective therapy to the current patient while preserving treatment effectiveness for future patients. Programs require infectious-disease expertise, pharmacy participation, microbiology support, nursing and medical engagement, information systems, and executive sponsorship.
8. Applied Case: A Cluster of Central-Line Bloodstream Infections
This is an illustrative case.
Background
A 300-bed hospital observed six laboratory-confirmed bloodstream infections associated with central venous catheters in one intensive-care unit over six weeks. The infections involved two bacterial species, and the rate exceeded the unit’s previous baseline.
Problem
Initial discussion focused on whether individual clinicians had failed to wash their hands. However, preliminary review found inconsistent documentation, variable access to insertion supplies, delays in dressing changes, and no recent competency assessment. Antibiotic use had also increased, but cultures were not always obtained before treatment.
Analysis
The infection-prevention team confirmed cases using a standardized definition and calculated the rate using central-line-days. They reviewed insertion and maintenance practices, supply availability, staffing, line necessity, environmental cleaning, microbiology results, and antibiotic exposure. Direct observation identified variation in skin antisepsis, hub disinfection, and dressing integrity checks. Interviews revealed that night-shift staff had limited access to the same standardized kits.
Approach and solution
The hospital introduced a central-line insertion and maintenance bundle; made standardized kits available on every shift; required competency validation; implemented a daily line-necessity review; strengthened hub-disinfection audits; and provided unit-level feedback. The stewardship team reviewed antibiotic starts and promoted culture collection before treatment when clinically safe. A non-punitive reporting process was used to identify supply and workflow barriers.
Outcome
Over the following months, the infection rate declined and documentation improved. The hospital continued monthly surveillance because an early decline could reflect random variation or under-reporting. Audits were repeated to ensure that process reliability, not only the outcome, had improved.
Learning points
The case demonstrates that HAIs are usually multifactorial. Effective response combines case confirmation, valid denominators, observation, supply-chain correction, training, leadership, feedback, and antimicrobial stewardship. Blaming individuals without correcting system conditions is unlikely to produce durable improvement.
9. Governance, Ethics, Technology, and Contemporary Practice
Infection prevention requires clear accountability. An infection-prevention committee should connect clinical departments, nursing, pharmacy, microbiology, occupational health, facilities, procurement, information technology, and executive leadership. Policies should define authority, escalation pathways, reporting obligations, and review intervals.
Patients have rights to privacy, understandable information, safe care, and respectful treatment. Surveillance data should be protected, access controlled, and reported in ways that support improvement without unnecessary identification. During outbreaks, transparency must be balanced with confidentiality and legal requirements.
Electronic health records can support automated alerts, isolation flags, vaccination reminders, device-day capture, and antimicrobial review queues. Artificial intelligence may help detect unusual clusters or predict risk, but it can reproduce bias, generate false alerts, and obscure reasoning. Human validation, data-quality checks, cybersecurity, and clinical accountability remain necessary. Technology should strengthen—not replace—professional judgment and direct observation.
Contemporary infection prevention increasingly emphasizes ventilation and indoor air quality, wastewater and genomic surveillance, climate-related changes in vector and pathogen distribution, resilient supply chains, and integration of human, animal, and environmental health. These developments reinforce the need for adaptive management rather than static policies.
Challenges and Limitations
No intervention is perfect. Hand-hygiene observation may suffer from observer effects; surveillance definitions may miss infections; laboratory capacity may be uneven; isolation can reduce patient interaction; and antimicrobial restrictions can delay necessary treatment. Metrics can create unintended incentives if managers reward low reported infection rates without checking ascertainment. Infection-control programs may also experience shortages of trained staff, personal protective equipment, single rooms, and reliable water or ventilation.
A mature program therefore uses multiple evidence sources, tests interventions in context, communicates uncertainty, and reassesses policies as pathogens, technologies, and evidence change. Education is essential but insufficient by itself. Reliable systems make the safe action the easy action.
Chapter Summary
Microbiology identifies the organisms and properties relevant to human disease, while immunology explains barriers, innate responses, adaptive immunity, memory, and the effects of vaccination. The chain of infection provides a practical framework for interrupting transmission through source control, environmental measures, personal protection, vaccination, and protection of susceptible hosts.
Cleaning, disinfection, antisepsis, and sterilization are distinct processes, and device classification determines the required level of reprocessing. Standard precautions apply to all patients; transmission-based precautions are added according to suspected route. Surveillance requires valid definitions, appropriate denominators, analysis, feedback, and action. AMR is driven by selection and spread of resistance, while antimicrobial stewardship promotes effective, safe, and appropriately narrow treatment.
At postgraduate level, infection prevention should be understood as a sociotechnical management system. Outcomes depend on leadership, staffing, supplies, workflow design, data quality, ethics, communication, and continuous improvement—not merely on individual knowledge.
Key Terms
Antimicrobial resistance: The ability of a microorganism to survive or grow despite an antimicrobial that would normally affect it.
Antimicrobial stewardship: Coordinated action to optimize antimicrobial use.
Antisepsis: Application of antimicrobial agents to living tissue.
Biofilm: A structured microbial community attached to a surface and embedded in extracellular material.
Colonization: Presence and multiplication of microorganisms without clinical disease.
Disinfection: Reduction or destruction of pathogens on inanimate objects, usually not reliably including spores.
HAI: Infection associated with healthcare delivery.
Innate immunity: Rapid, broadly acting host defense present before specific exposure.
Isolation: Separation or controlled management of a person to reduce transmission risk.
Microbiota: The microorganisms normally inhabiting a body site or environment.
Passive immunity: Temporary protection from transferred antibodies.
Portal of entry: Route by which an organism enters a susceptible host.
Portal of exit: Route by which an organism leaves its reservoir.
Reservoir: Person, animal, environment, or material in which an organism lives and multiplies.
Standard precautions: Basic infection-prevention measures used for every patient.
Sterilization: Validated destruction or removal of all forms of microbial life, including spores.
Surveillance: Systematic collection, analysis, interpretation, and use of health data for action.
Transmission-based precautions: Additional precautions selected for a suspected route of transmission.
Review Questions
5 Short Answer Questions
What are the six links in the chain of infection?
Distinguish colonization from infection.
Why is cleaning important before disinfection or sterilization?
What is the difference between active and passive immunity?
Why do gloves not replace hand hygiene?
5 Long Answer Questions
Explain the major modes of pathogen transmission and the infection-prevention measures appropriate to each.
Compare innate and adaptive immunity, including their principal cells, mechanisms, and relevance to vaccination.
Explain the Spaulding classification and relate it to the processing of critical, semicritical, and noncritical items.
Describe how a healthcare organization should design and govern an infection-control surveillance program.
Discuss the causes of antimicrobial resistance and the components of an effective antimicrobial-stewardship program.
3 Analytical / Application Questions
A surgical ward reports a sudden increase in postoperative infections. Design an investigation that distinguishes a true increase from a change in surveillance, diagnosis, or reporting.
A hospital has excellent written hand-hygiene policies but poor observed compliance. Analyze the likely system barriers and propose a measurable improvement plan.
A patient with suspected airborne infection requires urgent admission to a facility with limited isolation rooms. Develop a risk-based management plan that protects staff and other patients while preserving timely care.
Multiple Choice Questions with Answers
Question 1
Which statement best distinguishes colonization from infection?
A. Colonization always causes fever, whereas infection never does.
B. Colonization is the presence of microorganisms without tissue damage or symptoms, whereas infection involves host response or tissue invasion.
C. Colonization occurs only with viruses, whereas infection occurs only with bacteria.
D. Colonization always requires antimicrobial treatment.
Correct Answer: B. Colonization is the presence of microorganisms without tissue damage or symptoms, whereas infection involves host response or tissue invasion.
Question 2
Which intervention acts primarily by reducing host susceptibility?
A. Sterilizing surgical instruments
B. Improving ventilation
C. Vaccination
D. Disinfecting a bedside table
Correct Answer: C. Vaccination
Question 3
What is the minimum expected processing for an item that enters sterile vascular tissue?
A. Cleaning only
B. Low-level disinfection
C. High-level disinfection only
D. Sterilization
Correct Answer: D. Sterilization
Question 4
Which precaution applies to every patient regardless of suspected diagnosis?
A. Standard precautions
B. Airborne precautions
C. Droplet precautions
D. Protective isolation only
Correct Answer: A. Standard precautions
Question 5
A unit reports 4 device-associated infections during 2,000 device-days. Using a multiplier of 1,000, what is the infection rate?
A. 0.2 per 1,000 device-days
B. 2 per 1,000 device-days
C. 20 per 1,000 device-days
D. 500 per 1,000 device-days
Correct Answer: B. 2 per 1,000 device-days
Question 6
Which action is a core antimicrobial-stewardship intervention?
A. Continuing broad-spectrum therapy indefinitely
B. Avoiding cultures in all patients
C. Reassessing treatment when clinical and microbiological information becomes available
D. Using the same antibiotic for every infection
Correct Answer: C. Reassessing treatment when clinical and microbiological information becomes available
Question 7
Why can bacterial biofilms complicate healthcare-associated infections?
A. They prevent all immune responses permanently.
B. They are structured communities attached to surfaces and may be less susceptible to antimicrobials.
C. They occur only in community settings.
D. They are identical to bacterial spores.
Correct Answer: B. They are structured communities attached to surfaces and may be less susceptible to antimicrobials.
Question 8
Which is an example of indirect contact transmission?
A. A mosquito transmitting malaria
B. A contaminated instrument transferring organisms between patients
C. A patient inhaling suspended measles particles
D. A person acquiring infection through contaminated food
Correct Answer: B. A contaminated instrument transferring organisms between patients
Question 9
Which statement about surveillance is most accurate?
A. A low reported rate always proves that prevention is effective.
B. Surveillance is simply counting laboratory results without defined cases.
C. Surveillance requires standardized definitions, appropriate denominators, analysis, and action.
D. Surveillance should never include process indicators.
Correct Answer: C. Surveillance requires standardized definitions, appropriate denominators, analysis, and action.
Question 10
Which statement best describes passive immunity?
A. It develops only after natural infection and lasts permanently.
B. It results from transferred antibodies and is generally temporary.
C. It is produced exclusively by live vaccines.
D. It cannot protect immunocompromised patients.
Correct Answer: B. It results from transferred antibodies and is generally temporary.
Basic Health Sciences & Epidemiology
Chapter 4
of 15